Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Javier Escaned Added: 6 years ago
Prof Javier Escaned from Hospital Clinical San Carlos, Spain discusses DEFINE FLAIR & iFR SWEDEHEART: Safety of coronary revascularisation deferral based on iFR and FFR measurements in stable angina and ACS. Filmed by Radcliffe Cardiology on-site at EuroPCR 2017. View more
Added: 5 years ago
Pradaxa (dabigatran etexilate) is approved in various countries around the world for stroke prevention in patients with atrial fibrillation, primary prevention of venous thromboembolism in adult patients who have undergone elective total hip replacement surgery or total knee replacement surgery, and treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent… View more
Author(s): Denis Tack Added: 3 years ago
The overall increase in patient irradiation caused by the growing use of spiral- and multidetector-row computed tomography (MDCT) is of particular relevance for thoracic imaging. The number of clinical indications for thoracic CT has steadily increased, and CT has become a first-line imaging tool for diseases previously imaged with chest radiography, ventilation/perfusion scintigraphy and… View more
Author(s): Raman Dusaj , Jonathan S Reiner Added: 3 years ago
The rapid development of percutaneous coronary and peripheral vascular interventional technologies, as well as non-invasive computed tomography (CT)-based imaging systems, has led to a dramatic increase in the number of patients receiving intravenous or intra-arterial contrast media (CM). It has been estimated that more than 80 million doses (8 million litres) of contrast material are… View more
Author(s): Felix Mahfoud Added: 3 months ago
Join Prof Felix Mahfoud in this video on 'Safety and Efficacy of Renal Denervation'. View more
Author(s): Raman Dusaj , Jonathan S Reiner Added: 3 years ago
The rapid development of percutaneous coronary and peripheral vascular interventional technologies, as well as non-invasive computed tomography (CT)-based imaging systems, has led to a dramatic increase in the number of patients receiving intravenous or intra-arterial contrast media (CM). It has been estimated that more than 80 million doses (8 million litres) of contrast material are… View more
Author(s): John Petrie Added: 4 years ago
Prof John Petrie (University of Glasgow, Glasgow, UK) discuss Metformin safety and efficacy in ASCVD. Questions : 1. Can you give us a brief introduction to the role of metformin in ASCVD reduction? 2. What is the REMOVAL study and what did it measure? 3. Can you tell us the latest data from the REMOVAL subgroup studies? 4. Can you tell us the rationale behind the VA-IMPACT trial? 5. In the… View more
Start date: Apr 30, 2015 End date: Apr 30, 2015
Teams and Teamwork Who is it for? A one day symposium for all healthcare professionals and managers who are interested in leadership, teamwork and improving patient safety in acute cardiac care Speakers Dr Rod Stables, Liverpool Heart & Chest Hospital - Leading in Adversity Mr David Nott, Chelsea & Westminster Hospital Human Factors in Conflict Zones Mark de Rond, Judge Business School,… View more
Author(s): Marianne Brodmann Added: 5 years ago
Prof Marianne Brodmann (Medical University of Graz, AT) discusses safety of pacilitaxel coated balloons. Filmed on site by Radcliffe Cardiology. Questions: 1.There have been safety concerns with paclitaxel DCB's. What is your take on this? (00:09) 2.Are you still implanting drug coated balloons? (02:16) View more